Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Gennex Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:531739 P/E (TTM) :22.76
ISIN Demat:INE509C01026 Div & Yield %:0 EPS (TTM) :0.62
Book Value (RS) :7.8733175 Market Cap (Rs Cr.):320.93 Face Value (RS) :1
    Change Company 
YearsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.010.010.090.210.16
Long Term Debt-Equity Ratio0.000.000.000.000.00
Current Ratio5.925.162.951.941.78
Fixed Assets2.892.222.262.142.10
Inventory5.174.776.2810.2310.22
Debtors8.266.617.096.448.36
Interest Cover Ratio11.8013.725.896.787.84
PBIDTM (%)18.4722.5911.2010.3610.49
PBITM (%)17.7321.5010.169.159.11
PBDTM (%)16.9621.039.479.019.33
CPM (%)14.0917.037.437.227.73
APATM (%)13.3615.946.396.016.35
ROCE (%)10.2512.5010.6911.7813.17
RONW (%)7.909.457.419.3510.67

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)